UK regulators have approved nirogacestat as the first licensed drug for adults with progressive desmoid tumours.
The Cambridge, Massachusetts-based company – known as FogPharma until a rebrand in 2024 – needs cash for pivotal trials of ...
Nirogacestat therapy shows sustained benefits, including tumor shrinkage and durable responses, in long-term treatment of ...
1don MSN
We come to India looking for talent”, says Belen Garijo, Chair–Executive Board and CEO, Merck Group
Looking comfortable in a kurta, Belen Garijo, Chair–Executive Board and Chief Executive Officer of the German Science and ...
Founded in 2014, Springworks operates in Enterprise Tech offering solutions that help companies build a category-defining work culture. The product stack from ...
Founded in 2014, Springworks operates in Enterprise Tech offering solutions that help companies build a category-defining work culture. The product stack from ...
Researchers at the University of Michigan have identified a novel way to counter drug resistance in KRAS-mutant non-small ...
The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.
Investor's Business Daily on MSN
Biotech stocks' dark winter is over. What that means for investors.
The long winter for biotech stocks is over. Shares have climbed to levels not seen since late 2021, buoyed by eye-popping ...
Which Cars Are Most American? We analyze five factors to determine which new cars are the most American. Tesla Model 3 Tesla Model S Nissan Leaf Tesla Model Y Ford Mustang Mach-E Ford F-150 Lightning ...
[BRIEFING.COM] The stock market furthered its hot start to the first full trading week of the year today, with broad gains pushing the S&P 500 (+0.6%) and DJIA (+1.0%) to fresh record highs. The ...
Supreme Court will not rule on legality of tariffs Friday The court does not announce in advance what cases will be decided. It is unclear when it will issue its ruling on tariffs. Worldcategory· ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results